SATO Liverurso is a highly effective liver support supplement featuring ursodeoxycholic acid (UDCA) and a liver hydrolysate. UDCA is a bile acid that reduces cholesterol levels in bile, primarily by dispersing cholesterol and forming a liquid-crystalline phase. It influences enterohepatic circulation of bile salts, reducing the reabsorption of more hydrophobic and potentially toxic endogenous compounds in the intestines. UDCA exerts a direct hepatoprotective effect and reduces the hepatotoxicity of hydrophobic bile salts. It lowers the lithogenic index of bile, increasing the bile acid content. When taken orally, it contributes to the partial or complete dissolution of cholesterol gallstones. It also possesses choleretic properties (stimulates bile production). The liver hydrolysate further enhances liver protection, stimulating cleansing and restoration of liver and stomach function. It also helps alleviate stress and fatigue associated with intense physical exertion.
SATO Liverurso is indicated for a wide range of liver and biliary conditions, including:
SATO Liverurso is contraindicated in patients with:
Ursodeoxycholic acid, UDCA, liver protection, liver support, hepatoprotective, gallstones, cholesterol gallstones, biliary sludge, chronic hepatitis, acute hepatitis, non-alcoholic steatohepatitis (NASH), primary biliary cirrhosis, primary sclerosing cholangitis, cystic fibrosis liver, biliary atresia, biliary dyskinesia, liver cleanse, liver health, SATO Liverurso, liver supplement, bile acid, choleretic, liver hydrolysate.
US: temporary delays — postal services aligning new import rules, 
EU: 1–2 weeks, 🌍 Worldwide: 1–4 weeks ✈️